PTPRC and colorectal carcinoma: Among the 144 CRC patients, 101 (70.1%) patients had detectable CTCs including 36 patients (25.0%) with CD45− CTCs (CD45− CTCsonly) and 65 patients (45.1%) with CD45+ CTCs, with a mean number of 8 CTCs per 5 mL of blood sample.